news
ELIQUIS® (apixaban) approved in Europe for prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation
20 November 2012 | By Bristol-Myers Squibb Company
The EC has approved ELIQUIS®...
List view / Grid view
Bristol-Myers Squibb Company
news
FORXIGA™ (dapagliflozin) now approved in European Union for treatment of type 2 diabetes
14 November 2012 | By AstraZeneca
The European Commission has approved FORXIGA™ (dapagliflozin) tablets...
news
Investigational Triple DAA regimen of daclatasvir, asunaprevir and BMS-791325 achieved SVR12 of 94% in treatment-naïve patients with genotype 1 chronic hepatitis C infection in Phase II trial
12 November 2012 | By Bristol-Myers Squibb Company
Phase III development anticipated to begin in 2014...
news
Portola, Bristol-Myers Squibb and Pfizer sign clinical collaboration agreement
1 November 2012 | By Bristol-Myers Squibb Company
Portola Pharmaceuticals, Inc., Bristol-Myers Squibb Company and Pfizer announced a clinical collaboration agreement...
news
Bristol-Myers Squibb receives positive decision from NICE for YERVOY® (ipilimumab)
1 November 2012 | By Bristol-Myers Squibb Company
NICE has decided to recommend YERVOY®...
article
Non-Destructive Material Identification In-Depth Focus 2012
In this Non-Destructive Material Identification In-Depth Focus: An implementation perspective on handheld Raman spectrometers for the verification of material identity; Portable Raman spectroscopy for pharmaceutical counterfeit detection; Ask the Experts...
news
Bristol-Myers Squibb’s YERVOY® awarded prestigious Prix Galien USA prize for best biotechnology product
17 October 2012 | By Bristol-Myers Squibb Company
Yervoy also shortlisted for Prix Galien Prize in Germany...
news
U.S. Food and Drug Administration approves labeling update for BARACLUDE®
15 October 2012 | By Bristol-Myers Squibb Company
Studies provide data on BARACLUDE in special populations...
news
Sanofi and Bristol-Myers Squibb announce restructuring of alliance agreement
3 October 2012 | By Bristol-Myers Squibb Company
Sanofi & Bristol-Myers Squibb have restructured their long-term alliance...
news
Bristol-Myers Squibb appoints Frances Heller Senior Vice President, Business Development
28 September 2012 | By Bristol-Myers Squibb Company
Frances Heller will join as Senior VP, Business Development, on October 1...
news
ELIQUIS® (apixaban) receives positive opinion from CHMP
24 September 2012 | By Pfizer
For the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation...
news
Ten pharmaceutical companies unite to accelerate development of new medicines
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
webinar
Handheld Raman – Cut costs, improve efficiency & move toward 100% testing
18 September 2012 | By B&W Tek
In this free one hour instructional webinar you will learn how handheld Raman reduces costs and improves efficiency, the move to mandatory 100% testing of incoming raw materials, and recent developments in handheld Raman technology...
news
Summit enters technology license agreement with Bristol-Myers Squibb
11 September 2012 | By Peckwater PR
Summit has entered a technology license agreement with Bristol-Myers Squibb Company...
news
Bristol-Myers Squibb announces specialty pharmacy patient management programs for Sprycel® patients
15 August 2012 | By Bristol-Myers Squibb Company
Patient management programs for Sprycel® patients launched...
